beta hCG as a prognostic marker in prostatic adenocarcinoma.
AUTOR(ES)
Furness, P
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=500625Documentos Relacionados
- beta hCG as a prognostic marker in adenocarcinoma of the prostate.
- Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma.
- Presence of beta hCG mRNA in the human pituitary.
- Subdural metastases from prostatic adenocarcinoma.
- Isolated pulmonary metastases from prostatic adenocarcinoma.